Table 2 Characteristics of patients who survived more than 30 days (n = 4025).
From: Use of evidence-based pharmacotherapy after myocardial infarction in Estonia
Men | Women | |
|---|---|---|
Total number, (%) | 2365 (85.3) | 1660 (78.0)** |
Number of deaths, (%) | 302 (12.8) | 276 (16.6)** |
Number of treated patients, (%) | 2235 (94.5) | 1564 (94.2) |
Age (years; mean ± SD) | 64.73 ± 11.53 | 72.66 ± 9.90** |
20-39 years, No. (%) | 34 (1.44) | 4 (0.24)** |
40-59 years, No. (%) | 740 (31.29) | 166 (10.00)** |
60-79 years, No. (%) | 1383 (58.48) | 1075 (64.76)** |
80-99 years, No. (%) | 208 (8.79) | 415 (25.00)** |